Skip to main content

Table 4 Generalized linear model results of subcategories from phase 0 to phase 4

From: Network analysis for estimating standardization trends in genomics using MEDLINE

Phase

Category

B

SE

t

Sig.

95% Confidence Interval

 

Lower

Upper

 

Phase 0

Biologicals

0.647

0.911

0.710

0.478

-1.146

2.439

 

Clinical

0.004

0.875

0.005

0.996

-1.717

1.726

 

Company/Institute

0.022

1.078

0.020

0.984

-2.100

2.143

 

Data related

0.089

0.991

0.090

0.928

-1.861

2.040

 

Disease

0.739

0.868

0.851

0.395

-0.969

2.446

 

Gene

2.347

0.781

3.007

0.003**

0.812

3.883

 

Genetics terminology

0.299

0.783

0.382

0.703

-1.242

1.841

 

Methods

0.504

0.763

0.661

0.509

-0.996

2.005

 

Organism

2.338

1.226

1.907

0.057

-0.074

4.749

 

Pathogen

2.036

0.933

2.182

0.030*

0.200

3.873

 

Proteomics

1.160

1.180

0.983

0.326

-1.161

3.481

 

Software

-0.315

1.281

-0.246

0.806

-2.835

2.205

 

Phase 1

Biologicals

0.146

1.305

0.112

0.911

-2.422

2.714

 

Clinical

0.876

1.254

0.698

0.485

-1.591

3.342

 

Company/Institute

0.935

1.544

0.606

0.545

-2.103

3.974

 

Data related

0.849

1.420

0.598

0.550

-1.944

3.643

 

Disease

1.320

1.243

1.062

0.289

-1.125

3.765

 

Gene

3.256

1.118

2.912

0.004**

1.056

5.456

 

Genetics terminology

0.798

1.122

0.711

0.477

-1.410

3.006

 

Methods

0.487

1.093

0.445

0.656

-1.663

2.636

 

Organism

2.653

1.756

1.511

0.132

-0.801

6.108

 

Pathogen

2.320

1.337

1.735

0.084

-0.311

4.951

 

Proteomics

3.420

1.690

2.024

0.044*

0.095

6.745

 

Software

-0.555

1.835

-0.303

0.762

-4.165

3.055

 

Phase 2

Biologicals

-0.318

8.863

-0.036

0.971

-17.757

17.120

 

Clinical

-1.951

8.514

-0.229

0.819

-18.704

14.801

 

Company/Institute

3.622

10.490

0.345

0.730

-17.017

24.260

 

Data related

3.631

9.644

0.376

0.707

-15.343

22.605

 

Disease

1.089

8.441

0.129

0.897

-15.519

17.697

 

Gene

13.437

7.594

1.769

0.078

-1.504

28.377

 

Genetics terminology

8.486

7.622

1.113

0.266

-6.511

23.483

 

Methods

1.530

7.421

0.206

0.837

-13.070

16.131

 

Organism

8.160

11.925

0.684

0.494

-15.303

31.623

 

Pathogen

3.541

9.080

0.390

0.697

-14.325

21.407

 

Proteomics

38.460

11.478

3.351

0.001**

15.877

61.043

 

Software

11.910

12.461

0.956

0.340

-12.607

36.427

 

Phase 3

Biologicals

0.421

7.619

0.055

0.956

-14.570

15.412

Clinical

1.493

7.319

0.204

0.838

-12.908

15.894

Company/Institute

3.468

9.017

0.385

0.701

-14.274

21.209

Data related

1.631

8.290

0.197

0.844

-14.680

17.941

Disease

3.874

7.256

0.534

0.594

-10.403

18.151

Gene

11.117

6.528

1.703

0.090

-1.726

23.961

Genetics terminology

11.921

6.552

1.819

0.070

-0.971

24.813

Methods

-0.081

6.379

-0.013

0.990

-12.632

12.471

Organism

4.938

10.251

0.482

0.630

-15.232

25.107

Pathogen

4.255

7.806

0.545

0.586

-11.103

19.614

Proteomics

19.860

9.867

2.013

0.045*

0.446

39.274

Software

30.785

10.712

2.874

0.004**

9.709

51.861

Phase 4

Biologicals

2.348

8.725

0.269

0.788

-14.818

19.514

Clinical

9.000

8.381

1.074

0.284

-7.490

25.490

Company/Institute

4.385

10.326

0.425

0.671

-15.931

24.700

Data related

6.294

9.493

0.663

0.508

-12.383

24.971

Disease

7.179

8.309

0.864

0.388

-9.170

23.527

Gene

10.745

7.475

1.437

0.152

-3.963

25.452

Genetics term

15.587

7.503

2.077

0.039*

0.824

30.350

Methods

1.537

7.305

0.210

0.833

-12.835

15.909

Organism

5.778

11.738

0.492

0.623

-17.318

28.873

Pathogen

6.952

8.938

0.778

0.437

-10.634

24.539

Proteomics

11.700

11.299

1.036

0.301

-10.530

33.930

Software

15.750

12.256

1.284

0.200

-8.384

39.884